http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113875494-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a26df0ba02061e785811e69e79f9345
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01G18-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01G18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01G18-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G18-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G18-20
filingDate 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff46d4dca800867e003ad38ac78a072
publicationDate 2022-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113875494-A
titleOfInvention A method for culturing shiitake mushrooms capable of resisting cancer cell proliferation and regulating tumor immunity
abstract The invention relates to the technical field of shiitake mushroom cultivation, in particular to a method for culturing shiitake mushrooms with functions that can resist the proliferation of cancer cells and regulate tumor immunity, and solves the problems in the prior art that the in-depth development of high-tech, scientific and international shiitake mushrooms cannot be realized. (2) acquisition of functional Lentinus edodes mother seed liquid; (3) after culturing 96 hours around the tissue block, radial white new mycelia began to grow, and thereafter kept Cultivate at a temperature of 25°C ± 1°C for 5-7 days to obtain a functional Lentinus edodes mother seed solution; (4) make a culture medium of Astragalus Lentinus edodes; (5) make a functional Lentinus edodes cultivar; (6) fruiting. The invention makes full use of the advantages of traditional Chinese medicine in my country, modern biotechnology means and the latest scientific and technological research results, and successfully invents a functional shiitake mushroom with clear potential anti-cancer activity and cancer immune function regulation.
priorityDate 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108901607-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416192967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10920498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408435975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415817000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585919

Total number of triples: 44.